Medicare Enrolled
Dr. Mohammed Wada, M.D.
Pain Medicine · Alpharetta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wada from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wada?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wada
Dr. Mohammed Wada is a pain medicine specialist in Alpharetta, GA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Wada performed 2,732 Medicare services across 1,609 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wada received a total of $18,825 from 66 pharmaceutical and/or device companies across 549 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wada is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 20% volume in GA
$18,825 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,732
Medicare services
Top 20% in GA for pain medicine
1,609
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~171 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
634 | $59 | $300 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
406 | $71 | $498 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
237 | $1 | $7 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
192 | $12 | $249 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
185 | $77 | $1,600 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
177 | $54 | $1,200 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
108 | $105 | $1,088 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
79 | $83 | $1,800 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
79 | $57 | $800 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
78 | $101 | $2,000 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
76 | $215 | $2,400 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
66 | $60 | $1,200 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
56 | $41 | $680 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
55 | $81 | $952 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
54 | $80 | $398 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
52 | $51 | $600 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
38 | $90 | $272 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
31 | $117 | $572 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
30 | $191 | $2,400 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
28 | $110 | $1,632 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $37 | $200 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
27 | $63 | $1,000 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 16 | $358 | $2,300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,825
Total received (2018-2024)
Avg $2,689/year across 7 years
Top 6% in GA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
549
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,189 (75.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,504 (23.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$133 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,005
2023
$1,483
2022
$1,762
2021
$2,228
2020
$2,182
2019
$7,188
2018
$2,978
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$231
Saluda Medical Americas, Inc.
$162
BIOTRONIK NRO, Inc.
$109
Collegium Pharmaceutical, Inc.
$80
ABBVIE INC.
$60
Nevro Corp.
$58
Vertos Medical, Inc.
$50
Nalu Medical, Inc.
$47
Avanos Medical
$41
Virtus Pharmaceuticals LLC
$36
Abbott Laboratories
$24
SI-BONE, INC.
$24
PROTEGA PHARMACEUTIALS INC
$23
Medtronic, Inc.
$23
Lundbeck LLC
$22
Lilly USA, LLC
$16
Top 3 companies account for 49.8% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$6,184
Medtronic USA, Inc.
$2,032
Nevro Corp.
$1,703
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$922
Relievant Medsystems, Inc.
$600
Abbott Laboratories
$590
Collegium Pharmaceutical, Inc.
$497
Vertiflex, Inc.
$376
Horizon Therapeutics plc
$352
Avanos Medical
$325
Nalu Medical, Inc.
$285
US WorldMeds, LLC
$275
AbbVie Inc.
$260
Medtronic, Inc.
$258
BOSTON SCIENTIFIC CORPORATION
$217
Daiichi Sankyo Inc.
$203
Zyla Life Sciences, Inc.
$202
Saluda Medical Americas, Inc.
$201
SPR Therapeutics, Inc
$183
Allergan, Inc.
$179
ABBVIE INC.
$177
Forte Bio-Pharma LLC
$150
BIOTRONIK NRO, Inc.
$129
PFIZER INC.
$116
Virtus Pharmaceuticals LLC
$110
USWM, LLC
$109
Novartis Pharmaceuticals Corporation
$109
Biohaven Pharmaceutical Holding Company Ltd.
$108
BioDelivery Sciences International, Inc.
$105
Azurity Pharmaceuticals, Inc.
$102
Stimwave Technologies Incorporated
$101
Lilly USA, LLC
$99
ARBOR PHARMACEUTICALS, INC.
$92
TerSera Therapeutics LLC
$92
Nuvectra Corporation
$89
Orthogenrx Inc.
$80
Sentynl Therapeutics, Inc.
$80
Takeda Pharmaceuticals U.S.A., Inc.
$77
Almatica Pharma LLC
$74
SI-BONE, INC.
$71
RedHill Biopharma Inc.
$67
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$66
Purdue Pharma L.P.
$52
Assertio Therapeutics, Inc.
$50
AstraZeneca Pharmaceuticals LP
$50
Vertos Medical, Inc.
$50
Teva Pharmaceuticals USA, Inc.
$48
Horizon Pharma plc
$45
Lundbeck LLC
$45
Kaleo, Inc.
$44
Kowa Pharmaceuticals America, Inc.
$44
Vertical Pharmaceuticals, LLC
$41
GRT US Holding, Inc.
$39
Arbor Pharmaceuticals, Inc.
$39
Radius Health, Inc.
$31
FORTE BIO-PHARMA LLC
$27
Pernix Therapeutics Holdings, Inc.
$23
Amgen Inc.
$23
PROTEGA PHARMACEUTIALS INC
$23
Merit Medical Systems Inc
$21
Stryker Corporation
$18
Electronic Waveform Lab, Inc.
$18
Spinal Simplicity, LLC
$16
Zyla Life Sciences
$12
IBSA Pharma Inc.
$11
SI-BONE, Inc.
$9
Top 3 companies account for 52.7% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · AIMOVIG · AJOVY · Aemcolo · Aimovig · Algovita · Amitiza · BELBUCA · BIOTRONIK · BOTOX · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · COLOGUARD · COOLIEF COOLED RADIOFREQUENCY · DUEXIS · EMGALITY · ETERNA · Evoke · Evoke SCS · Evzio · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GENERATOR · GRALISE · GenVisc 850 · General - Pain Management · HA MINUTEMAN G3-R · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - IVAS · Intracept · LEVORPHANOL TARTRATE · LORZONE · LYRICA · Levorphanol · Levorphanol Tartrate · Licart · Lucemyra · Lucemyra/Lofexidine · MOTEGRITY · MOVANTIK · Morphabond ER · Motegrity · Movantik · NAPRELAN · NURTEC ODT · Nalocet · Nalu Neurostimulation System · Omnia · PENNSAID · PRIALT · PROCLAIM · PROLATE · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prospera · QULIPTA · Qutenza · RAYOS · RELEXXII · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · ROXYBOND · SEGLENTIS · SPECIFY · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · STANDARD RF DISPOSABLES · SUPERION · SYMJEPI · SYMPROIC · Seglentis · Senza · Senza Spinal Cord Stimulation System · StabiliT System · StimQ Peripheral Nerve StimulatorSystem · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion ISS · Tymlos · UBRELVY · VECTRIS · VERTIFLEX SUPERION · VYEPTI · Vanta · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · ZIPSOR · ZOHYDRO ER · Zipsor · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for pain medicine in GA.
Geographic Context
Pain medicines within 10 mi
57
Per 100K population
5.3
County median income
$91,490
Nearest hospital
EMORY JOHNS CREEK HOSPITAL
6.0 mi
6.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wada is a clinical cardiology specialist, with above-average Medicare volume (top 20% in GA), with low-engagement industry engagement in the top 6% of GA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wada experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Wada performed 634 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wada receive payments from pharmaceutical companies?
Yes. Dr. Wada received a total of $18,825 from 66 companies across 549 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wada's costs compare to other pain medicines in Alpharetta?
Dr. Wada's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wada) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Alpharetta
Browse pain medicines in Alpharetta ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in GA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in GA
Which GA pain medicines receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology